- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Precision Cancer Therapies market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Precision Cancer Therapiesmarket, defines the market attractiveness level of Precision Cancer Therapies market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Precision Cancer Therapies industry, describes the types of Precision Cancer Therapies market, the applications of major players and the market size, and deeply analyzes the current situation of the global Precision Cancer Therapies market and the development prospects and opportunities of Precision Cancer Therapies industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Precision Cancer Therapies market in Chapter 13.
By Player:
Hospira
OncoGenex Pharmaceuticals
Boehringer Ingelheim
AstraZeneca
Bayer HealthCare
Aveo Pharmaceuticals
Abbott Laboratories
GlaxoSmithKline
By Type:
Hormone Therapy
Immunotherapies
Targeted Therapy
Monoclonal Antibody Therapy
Gene Therapy
By End-User:
Hospitals
Diagnostic Centers
Oncology Clinics
Research Institutes
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Precision Cancer Therapies Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Precision Cancer Therapies Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Precision Cancer Therapies Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Precision Cancer Therapies Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Precision Cancer Therapies Market Analysis and Outlook to 2022
-
7.1 Global Precision Cancer Therapies Consumption (2017-2022)
-
7.2 United States Precision Cancer Therapies Consumption (2017-2022)
-
7.3 Europe Precision Cancer Therapies Consumption (2017-2022)
-
7.4 China Precision Cancer Therapies Consumption (2017-2022)
-
7.5 Japan Precision Cancer Therapies Consumption (2017-2022)
-
7.6 India Precision Cancer Therapies Consumption (2017-2022)
-
7.7 South Korea Precision Cancer Therapies Consumption (2017-2022)
8 Region and Country-wise Precision Cancer Therapies Market Analysis and Outlook to 2028
-
8.1 Global Precision Cancer Therapies Consumption Forecast (2022-2028)
-
8.2 United States Precision Cancer Therapies Consumption Forecast (2022-2028)
-
8.3 Europe Precision Cancer Therapies Consumption Forecast (2022-2028)
-
8.4 China Precision Cancer Therapies Consumption Forecast (2022-2028)
-
8.5 Japan Precision Cancer Therapies Consumption Forecast (2022-2028)
-
8.6 India Precision Cancer Therapies Consumption Forecast (2022-2028)
-
8.7 South Korea Precision Cancer Therapies Consumption Forecast (2022-2028)
9 Global Precision Cancer Therapies Market Outlook by Types and Applications to 2022
-
9.1 Global Precision Cancer Therapies Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Hormone Therapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Immunotherapies Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Monoclonal Antibody Therapy Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Gene Therapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Precision Cancer Therapies Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diagnostic Centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Oncology Clinics Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Research Institutes Consumption and Growth Rate (2017-2022)
10 Global Precision Cancer Therapies Market Outlook by Types and Applications to 2028
-
10.1 Global Precision Cancer Therapies Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Hormone Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Immunotherapies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Monoclonal Antibody Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Precision Cancer Therapies Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Oncology Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
11 Global Precision Cancer Therapies Import and Export Analysis (Top 5 Countries)
-
11.1 Global Precision Cancer Therapies Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Precision Cancer Therapies Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Precision Cancer Therapies Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Precision Cancer Therapies Market Competitive Analysis
-
14.1 Hospira
-
14.1.1 Hospira Company Details
-
14.1.2 Hospira Precision Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Hospira Precision Cancer Therapies Product and Service
-
14.2 OncoGenex Pharmaceuticals
-
14.2.1 OncoGenex Pharmaceuticals Company Details
-
14.2.2 OncoGenex Pharmaceuticals Precision Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 OncoGenex Pharmaceuticals Precision Cancer Therapies Product and Service
-
14.3 Boehringer Ingelheim
-
14.3.1 Boehringer Ingelheim Company Details
-
14.3.2 Boehringer Ingelheim Precision Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Boehringer Ingelheim Precision Cancer Therapies Product and Service
-
14.4 AstraZeneca
-
14.4.1 AstraZeneca Company Details
-
14.4.2 AstraZeneca Precision Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AstraZeneca Precision Cancer Therapies Product and Service
-
14.5 Bayer HealthCare
-
14.5.1 Bayer HealthCare Company Details
-
14.5.2 Bayer HealthCare Precision Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bayer HealthCare Precision Cancer Therapies Product and Service
-
14.6 Aveo Pharmaceuticals
-
14.6.1 Aveo Pharmaceuticals Company Details
-
14.6.2 Aveo Pharmaceuticals Precision Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Aveo Pharmaceuticals Precision Cancer Therapies Product and Service
-
14.7 Abbott Laboratories
-
14.7.1 Abbott Laboratories Company Details
-
14.7.2 Abbott Laboratories Precision Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Abbott Laboratories Precision Cancer Therapies Product and Service
-
14.8 GlaxoSmithKline
-
14.8.1 GlaxoSmithKline Company Details
-
14.8.2 GlaxoSmithKline Precision Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 GlaxoSmithKline Precision Cancer Therapies Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Precision Cancer Therapies
-
Figure Precision Cancer Therapies Picture
-
Table Global Precision Cancer Therapies Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Precision Cancer Therapies Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Precision Cancer Therapies Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Precision Cancer Therapies Consumption by Country (2017-2022)
-
Figure United States Precision Cancer Therapies Consumption and Growth Rate (2017-2022)
-
Table Europe Precision Cancer Therapies Consumption and Growth Rate (2017-2022)
-
Figure China Precision Cancer Therapies Consumption and Growth Rate (2017-2022)
-
Figure Japan Precision Cancer Therapies Consumption and Growth Rate (2017-2022)
-
Figure India Precision Cancer Therapies Consumption and Growth Rate (2017-2022)
-
Figure South Korea Precision Cancer Therapies Consumption and Growth Rate (2017-2022)
-
Figure Global Precision Cancer Therapies Consumption Forecast by Country (2022-2028)
-
Figure United States Precision Cancer Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Precision Cancer Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Precision Cancer Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Precision Cancer Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Precision Cancer Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Precision Cancer Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hormone Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapies Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibody Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Hormone Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibody Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Precision Cancer Therapies Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Precision Cancer Therapies Export by Region (Top 5 Countries) (2017-2028)
-
Table Hospira (Foundation Year, Company Profile and etc.)
-
Table Hospira Precision Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hospira Precision Cancer Therapies Product and Service
-
Table OncoGenex Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table OncoGenex Pharmaceuticals Precision Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table OncoGenex Pharmaceuticals Precision Cancer Therapies Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Precision Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Precision Cancer Therapies Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Precision Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Precision Cancer Therapies Product and Service
-
Table Bayer HealthCare (Foundation Year, Company Profile and etc.)
-
Table Bayer HealthCare Precision Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer HealthCare Precision Cancer Therapies Product and Service
-
Table Aveo Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Aveo Pharmaceuticals Precision Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aveo Pharmaceuticals Precision Cancer Therapies Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Precision Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Precision Cancer Therapies Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Precision Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Precision Cancer Therapies Product and Service
-